Gene expression profiling of tumor-stromal interactions between pancreatic cancer cells and stromal fibroblasts

被引:129
作者
Sato, N
Maehara, N
Goggins, M
机构
[1] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA
[2] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA
[3] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA
关键词
D O I
10.1158/0008-5472.CAN-04-0677
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The interactions between cancer cells and surrounding stroma play a critical role in tumor progression, but their molecular basis is largely unknown. Global gene expression profiling was performed using oligonucleotide microarrays to determine changes in the gene expression of pancreatic cancer cells (CFPAC1) and stromal fibroblasts induced by coculture. This analysis identified multiple genes as differentially expressed in pancreatic cancer cells and in fibroblasts as a consequence of their mutual interactions, including those that encode for proteins associated with tumor invasion, metastasis, and angiogenesis. Among the genes identified, the cyclooxygenase-2 (COX-2)/PTGS2 gene was of particular interest because COX-2 expression was markedly augmented in both cell types (cancer cells and fibroblasts) in response to coculture. Coculture with fibroblasts also induced COX-2 expression in additional pancreatic cancer cells with an unmethylated COX-2 promoter, but not in those with a methylated COX-2 promoter. Using an in vitro invasion assay, we found an increase in the invasive potential of CFPAC1 cells when they were cocultured with fibroblasts, an effect blocked partially by the addition of a selective COX-2 inhibitor, NS-398, or by COX-2 knockdown with small interfering RNA. Thus, COX-2 inhibitors can decrease the invasive properties of pancreatic cancer cells acquired through tumor-stromal interactions.
引用
收藏
页码:6950 / 6956
页数:7
相关论文
共 51 条
[1]  
Anderson IC, 2000, CANCER RES, V60, P269
[2]   TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia [J].
Bhowmick, NA ;
Chytil, A ;
Plieth, D ;
Gorska, AE ;
Dumont, N ;
Shappell, S ;
Washington, MK ;
Neilson, EG ;
Moses, HL .
SCIENCE, 2004, 303 (5659) :848-851
[3]   Timeline - Matrix metalloproteinases: a tail of a frog that became a prince [J].
Brinckerhoff, CE ;
Matrisian, LM .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (03) :207-214
[4]  
Chu JS, 2003, MOL CANCER THER, V2, P1
[5]   Initial experience combining cyclooxygenase-2 inhibition with chemoradiation for locally advanced pancreatic cancer [J].
Crane, CH ;
Mason, K ;
Janjan, NA ;
Milas, L .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (04) :S81-S84
[6]   Targeting cyclooxygenase-2 in human neoplasia: Rationale and promise [J].
Dannenberg, AJ ;
Subbaramaiah, K .
CANCER CELL, 2003, 4 (06) :431-436
[7]   Induction of G0/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference [J].
Denkert, C ;
Fürstenberg, A ;
Daniel, PT ;
Koch, I ;
Köbel, M ;
Weichert, W ;
Siegert, A ;
Hauptmann, S .
ONCOGENE, 2003, 22 (54) :8653-8661
[8]  
Ding XZ, 2000, ANTICANCER RES, V20, P2625
[9]   Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion [J].
Dohadwala, M ;
Batra, RK ;
Luo, J ;
Lin, Y ;
Krysan, K ;
Pold, M ;
Sharma, S ;
Dubinett, SM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (52) :50828-50833
[10]   Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells [J].
Dong, Z ;
Nemeth, JA ;
Cher, ML ;
Palmer, KC ;
Bright, RC ;
Fridman, R .
INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (04) :507-515